News

Media Contact

media.inquiries@kaleo.com

Woman working on laptop

Recent News

National Organizations Unite to Prepare Early Childcare Facilities for Rising Incidence of Food Allergies

Kaléo Receives Inaugural Medical CBRN Defense Consortium Innovation Award for Prototype Development of its Rapid Opioid Countermeasure System (Naloxone HCl Injection, USP) Antidote

Kaleo’s AUVI-Q® (epinephrine injection, USP) Selected by Axiom Space to Help Protect Crew from Allergic Emergencies

Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other Epinephrine Auto-Injectors